News

New Study Advances Search for Accurate Blood Markers for Acute Kidney Injury

Findings seen as a step toward ending need for invasive kidney biopsies to predict AKI, and to help manage and assess treatment of serious kidney inflammations.

News

How PIN Turns to Prostate Cancer

If you’ve had a prostate biopsy, you may have seen the words “prostatic intraepithelial neoplasia (PIN)” on the pathology report. What is it? Based on years of study, much of it led by Brady scientists, “we recognize PIN as a warning sign ...

News

Déjà Vu: Transforming How Surgery is Practiced and Performed

On his computer screen, urologist Ahmed Ghazi, M.B.B.Ch., M.D., is showing a strange video: a radical prostatectomy in double vision. The screen is split, and the operation seems to be shown in duplicate. On both sides of the screen, the ...

News

Focal Therapy: Killing the Cancer, Not the Prostate

Focal therapy, although not the standard of care, is emerging as a way to treat localized prostate cancer in carefully selected patients. The Brady is proud that one of the leaders in this field, urologist Arvin K. George, M.B.B.Ch., is ...

News

Who Will Benefit from Immunotherapy for Metastatic ccRCC?

Important clues can be found in routine pathology slides. Immunotherapy drugs called “checkpoint inhibitors” have revolutionized treatment for patients with metastatic clear cell renal carcinoma (ccRCC), the most common type of kidney cancer.

News

What do MicroRNAs Have to Do with Inherited Prostate Cancer?

The genes linked to prostate cancer – that we know of — are just the tip of the iceberg. What about the other 98 percent of the genome?

News

Urine “Liquid Biopsies” for Bladder Cancer

“Our current methods to detect the presence of bladder and upper tract urothelial cancers are suboptimal,” says David McConkey, Ph.D., Director of the Johns Hopkins Greenberg Bladder Cancer Institute.

News

Treating Kidney Cancers with Proton Therapy

There is no one-size-fits-all therapy for localized kidney cancer. For example, surgery, the mainstay of treatment, is not an option for patients who have other serious medical conditions or complicated tumor presentations.

News

Treating High-Risk Kidney Cancer Before it Spreads

Is it a question of timing? Should we try the drug even earlier? “When cancer is localized within the kidney, nephrectomy (kidney removal) is the treatment of choice,” says Mohamad Allaf, M.D.

News

Super-sized, Chemo-Resistant Cancer Cells

Some cancer cells basically thumb their nose at treatment. Other cells may succumb, but not these hardy survivors.

News

Salvage Radiation after Prostatectomy: Watch the PSA!

To minimize risk of metastases, treat with salvage radiation while PSA is below 0.5. If PSA becomes detectable and starts to rise after prostatectomy, salvage radiation can still cure the cancer.

News

Patients Talked; We Listened, Studied, and Came Up with a Plan to Make it Better. Now We Want to Test it.

Every facet of ERAS targets factors of delayed recovery, such as slow return of bowel and urinary function, immobility, and pain.

News

New Clues to Treating Two Forms of Bladder Cancer

Small cell/neuroendocrine bladder cancers (SCBCs) are rare, highly aggressive, and difficult to treat. But in a recent study, published in European Urology, Brady scientist Woonyoung Choi, Ph.D., and colleagues have gained insights that ...

News

Narrowing the Racial Gap in Prostate Cancer

“Despite advances in early detection, prevention, and treatment, Black men in the U.S. remain disproportionately affected by prostate cancer,” says urologist Arthur Burnett, M.D., the Patrick C. Walsh Professor of Urology.

News

Kidney Cancer and Race

Why are Black patients more likely than White patients to die of kidney cancer? Nirmish Singla, M.D., M.Sc., Director of the Kidney Cancer Program, is leading research efforts to find out more.

News

Inherited Prostate Cancer in Black Men

Previously in Discovery, we reported that the first-known prostate-specific cancer susceptibility gene, HOXB13, identified in 2012 by Brady scientist William Isaacs, Ph.D., and colleagues – had thrown researchers a curve ball: For a decade, ...

News

Inflammation, Club Cells, and Prostate Cancer

What’s wrong with inflammation? Sometimes, it is good. For example, when you skin your knee, inflammation protects your body from bacteria and germs.

News

In-Depth Study of ccRCC Yields New Insights

In a series of elegant studies, pathology scientists Hui Zhang, Ph.D., M.S., and T. Mamie Lih, Ph.D., together with investigators from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), have discovered several new ways of characterizing ...

News

Improving Quality of Life After Radical Cystectomy

Do all those organs need to come out? Radical cystectomy is a tough operation. It’s not just removal of the bladder: in men, it includes removing the prostate and seminal vesicles, and in women, it includes removing the anterior vaginal ...

News

AI and Your Prostate Cells on a Slide

Nobody has a crystal ball that will accurately predict exactly what someone’s prostate cancer will do – but Hopkins pathologists are working on it.

News

Active Surveillance in Small Kidney Cancers

In years past, kidney cancer was treated immediately after it was detected. But now we know that not all kidney cancer needs to be treated right away; some small renal masses (SRM; less than 4 cm) may never need treatment.

News

A Passion for Advocacy

The AUA's selection committee was impressed with Galansky's "unmatched understanding of public policy."

News

A Fortunate Misdiagnosis

More than 60 years ago, a beautiful friendship began with a life-changing second opinion.

News

“Bipolar” Androgen Therapy (BAT) Trials Under Way

Several years ago, Samuel Denmeade, M.D., Director of the Division of Genitourinary Oncology at the Sidney Kimmel Comprehensive Cancer Center, and colleagues came up with a new concept for treating advanced prostate cancer that seemed ...

News

Who Can Safely Remain on Active Surveillance?

New studies provide guidance.

News

Looking for Bad Genes

Scrutinizing 25,000 genes in 8,000 men with prostate cancer.

News

Lowering the Risk of Recurrent Prostate Cancer

Exciting results from a Hopkins-led study have catapulted a lowly immune system protein into the spotlight as a promising new target for prostate cancer immunotherapy.

News

Bladder Exstrophy Archives

Johns Hopkins Medicine Bladder Exstrophy Archives

News

Precision Medicine: Genetics and Clinical Outcomes in Advanced Prostate Cancer

No two men with prostate cancer have exactly the same disease. Instead, each has distinct genomic and molecular changes that make the cancer more or less likely to respond to a particular treatment – and scientists still have much to learn ...

News

Newly Discovered Mutation on HOXB13 is Linked to More Aggressive Cancer in Black Men

Three decades ago, Brady investigators William Isaacs, Ph.D., the William Thomas Gerrard, Mario Anthony Duhon, and Jennifer and John Chalsty Professor of Urology, and Patrick Walsh, M.D., characterized hereditary prostate cancer, and in ...

News

Recent Brady Honors & Awards

Burnett was recognized for his “groundbreaking advances in male sexual health, as well as advocacy, diversity and humanitarian contributions.”

News

Schaufeld Program Celebrates First Year

Last year in Discovery, we introduced an exciting new initiative, the Schaufeld Program for Prostate Cancer in Black Men, which addresses a critical issue: Black men are more likely to develop aggressive prostate cancer, and to die of it, than other men.

News

Read About the Research You Have Helped Make Possible.

How important is seed money? Priceless! Many of the scientists featured in this issue of Discovery jump-started their research careers with awards from the Patrick C. Walsh Prostate Cancer Research Fund.

News

GSTP1: Could This Gene Be Linked to Cancer Death in Black Men?

Black men in the U.S. are nearly twice as likely to die of prostate cancer than white men. What accounts for this terrible statistic?

News

Kidney Cancer and Brain Metastases

Most people with kidney cancer don’t have metastasis to the brain. But 15 percent of patients with advanced kidney cancer do, says urologic oncologist Nirmish Singla, M.D., M.S.C.S., Director of the Kidney Cancer Program.

News

Kidney Cancer Program: World-class Care and Research

The Kidney Cancer Program (KCP), jointly led by urologist Nirmish Singla and oncologist Yasser Ged, was established with the goal of offering world-class, multidisciplinary clinical care and cutting-edge collaborative research “to continuously ...

News

Prostate Cancer in Transgender Patients

Although it is quite rare, aggressive prostate cancer can occur in transgender patients on long-term hormone therapy.

News

Turning Back the Clock on Treatment-Resistant Prostate Cancer

If this hypothesis proves true, an LSD1-blocking agent could allow ADT and AR-blocking drugs to work again in men with mCRPC.

News

Race, Ethnicity and Clinical Trials

There are significant differences in cancer – even the same type of cancer – among people of different racial and ethnic backgrounds.

News

Therapy Resistance in Cancer: Learning from Bacteria

Why is metastatic prostate cancer so hard to kill? The short answer is that nobody knows.

News

Managing a Tumor Thrombus in Kidney Cancer

Managing Kidney Cancer “Some patients with renal cell carcinoma (RCC) display a unique pattern of local invasion known as tumor thrombus: the cancer invades the major vein that drains the kidneys and can potentially climb up to the heart,” ...

News

Neoadjuvant Therapy and High-Risk Localized Prostate Cancer

The next step is a multicenter randomized, placebo-controlled trial of Enoblituzumab.

News

Neoadjuvant Chemotherapy and Surgery for MIBC: What’s a Successful Response?

Neoadjuvant chemotherapy is the standard of care for cisplatin-eligible patients with MIBC who undergo radical cystectomy (removal of the bladder).

News

Exercise, Immunotherapy, and Metastatic Kidney Cancer

Obesity is a known risk factor for renal cell carcinoma, and patients with renal cell carcinoma who have muscle mass loss have a less favorable prognosis,” says medical oncologist Yasser Ged, M.B.B.S.

News

Embryonic Genes Reactivated in Advanced Prostate Cancer

Embryonic genes are supposed to fulfill their mission before we are ever born and then shut themselves off. But somehow, metastatic castration-resistant prostate cancer (mCRPC) manages to reactivate these genes from our period of earliest development.

News

Finding Metastatic Prostate Cancer that Doesn’t Make PSMA

Two huge advances have dramatically changed the diagnosis and treatment of metastatic prostate cancer, and both of these involve prostate-specific membrane antigen (PSMA), a molecule that sits on the surface of prostate cancer cells.

News

DNA Damage-Repair Gene Mutations and Neoadjuvant Chemotherapy in MIBC

Mutations in DNA damage-repair (DDR) genes – the best-known of these genes are BRCA1/2, linked to breast, ovarian, colon and prostate cancer – make it more likely that someone will get cancer, and get a more aggressive form of it. But ...

News

After 45 Years at the Brady, John Isaacs Retires

In 2022, after a 45-year career at Hopkins, John T. Isaacs, Ph.D., Professor of Oncology and Urology, retired. John is a pioneer in the translation of basic science theory into clinical trials for lethal prostate cancer.

News

A Novel Study for Patients with Small Cell Bladder Cancer

Hoffman-Censits and Hopkins colleagues are testing the combination of the FDA-approved checkpoint inhibitor, Atezolizumab, and standard chemotherapy in patients with newly diagnosed, localized SCBC.

News

Gleason 3+3=6 is Not “Not Cancer”

Grade Group 1 cancer has some of the same behaviors as higher grade cancer. It’s invasive, and it can appear in perineural invasion and extra prostatic extension

News

For Prostate Cancer Patients with Mismatch Repair Deficiency, Immunotherapy Alone?

All patients in the study will receive nivolumab, a form of immunotherapy, without the addition of ADT

News

Gut Bugs and Treatment Response in Metastatic Prostate Cancer

Even as medications work to suppress levels of male hormones, certain bacteria in the gut start their own hormone factory.

News

Low-Intensity Electrostimulation May Improve Erectile Recovery

Low-intensity electrostimulation has been shown to enhance peripheral nerve regeneration. Can it stimulate regeneration in the nerves that control erection, and improve recovery of erectile function after prostatectomy?

News

The PROMISE of Studying Inherited Genes

Men who participate will get free, medical-grade, hereditary cancer risk testing and access to a licensed genetic counselor to help them understand the results.

News

Goodbye, CT and Bone Scans?

The National Comprehensive Cancer Network (NCCN) has recognizing the increased sensitivity and specificity of PSMA- PET compared to conventional imaging (CT, MRI, bone scans) for detecting micrometastatic disease, at both initial staging ...

News

Read About the Research You Have Helped Make Possible: the Patrick C. Walsh Prostate Cancer Research Fund

How important is seed money? Priceless! Our cover story, on Martin Pomper’s PSMA-targeting research, is an excellent example.

News

For Advanced Prostate Cancer: Immunotherapy and… Testosterone?

Could the flat-out opposite of conventional wisdom prove to be effective against metastatic prostate cancer?

News

Renal Cell Carcinoma: Immunotherapy Before Nephrectomy

Checkpoint inhibitors may work best “when the kidney and kidney tumor are still in place, because there are more cancer cells and molecules for the immune system to recognize and treat."

News

Team Discovers Unique Immune Cells in RCC

A team led by cancer immunologists Debebe Theodros, M.D., Ph.D., and Jelani Zarif, Ph.D., has found something new in renal cell carcinoma (RCC)

News

Why Can Dogs Detect Prostate Cancer?

Dogs can smell prostate cancer. In fact, out of a bunch of urine samples, they can even distinguish aggressive prostate cancer from low-risk or intermediate cancer.

News

The Patrick C. Walsh Hereditary Prostate Cancer Program

“To reduce deaths from prostate cancer, we must identify men at risk of lethal prostate cancer when cure is still possible. The best way to do that is through genetic testing.”

News

Cholesterol, Prostate Cancer, and Race

There’s a connection between cholesterol and the risk of aggressive prostate cancer. It’s not fully understood, and a new study by Johns Hopkins investigators has uncovered a further wrinkle: race.

News

A Challenging Opportunity

“For the first time, we have the potential to identify every gene involved in HPC, and to help thousands of men and their families understand their family cancer risk, seek early detection and treatment, and save many lives.”

News

Multidisciplinary Clinic for Patients with UTUC

For more than 130 years, Johns Hopkins has provided expertise in treating difficult and rare diseases that doctors at some hospitals might never even come across: diseases like UTUC.

News

Stepping Up to Help

In the dark early months of the Covid-19 pandemic, there was a shortage of reliable Covid-19 tests.

News

Insights into Aggressive Cancer: Cellular Garbage Strikes and Sneaky Sleepers

Scientists Sarah Amend, Ph.D., Ken Pienta, M.D., and colleagues are very interested in a specialized type of immune cell, called an M2-like macrophage.

News

Changing the Odds

Within a few miles of Johns Hopkins are thousands of men who have the highest risk of dying from aggressive prostate cancer in the world.

News

A Domino Chain of Discovery

Four decades ago, Patrick Walsh started an ongoing series of discoveries that transformed the field of prostate cancer research and treatment.

News

The PSMA-Targeting Era: A Game-Changer for Men with Prostate Cancer Worldwide

PSMA is tiny; you couldn’t see it if you tried with the naked eye. It’s just a protein, one of about 2 million in the human body. So why are doctors and patients so excited about it?

News

Partin Stepping Down as Director

After 17 years, urologist Alan Partin, M.D., Ph.D., is stepping down as the Jakurski Family Director of The Brady Urological Institute, Urologist-in-Chief for Johns Hopkins Medicine, and Director of the Department of Urology.

News

Spotlight on UTUC

An estimated 9,000 Americans each year are diagnosed with upper tract urothelial cancer (UTUC), which affects the renal pelvis or ureter and is difficult to treat.

News

Neoadjuvant Chemotherapy and Muscle-Invasive Bladder Cancer

Having one or more mutated DNA damage repair (DDR) genes – “spell-checkers” that normally stop faulty genes from replicating – has been linked to a better response to neoadjuvant (presurgical) chemotherapy in muscle-invasive bladder cancer (MIBC).

News

Treatment Goals for NMIBC: What Do Patients Think?

In recent years, new clinical trial guidelines from the Food and Drug Administration (FDA) have stimulated the development of new drugs for non-muscle-invasive bladder cancer (NMIBC).

News

Men and Women Respond Differently to Immune Checkpoint Blockade

Immune checkpoints are like tiny brakes that immobilize immune cells that otherwise could be fighting cancer.

News

New Guidance for Treating Early Testicular Cancer

Most men (94 to 100 percent) with early-stage testicular cancer, confined to the testicle or lymph nodes that drain the testicles, are cured. “For these men, the difficulty is to determine the best treatment strategy,” says urologist Phillip ...

News

Ultrasound and Testicular Tumors

Not all testicular lumps – particularly, those smaller than 2 cm, as seen on ultrasound – are cancer; some are not. “Most men with a testicular mass greater than 2cm have cancer, but for many men with a mass less than 2cm, it is a benign ...

News

“Unclassifiable” Kidney Cancer: New Insights

There are less common types of RCC, such as papillary and chromophobe – and then there are a number of kidney tumors each year that don’t fit any of these categories, and thus are known as “unclassified RCC.”

News

RCC: Local Recurrence Can Be Cured with Surgery

“More than half of these patients were cured with a second surgery, and were able to avoid systemic chemotherapy.”

News

Urogynecological Surgery Case Study—New Program’s Minimally Invasive Approach

Treatment options for stress incontinence included a pessary, a suture procedure, non-mesh slings, and permanent mesh slings.

News

JAMA Study: Immunotherapy May Affect Male Fertility

This study is the first to link immunotherapy for cancer with reduced sperm-producing cells.

News

Early-Stage Testicular Cancer: Treating with Surgery Alone?

A new Brady study, published in European Urology Focus, finds that in addition to preventing unnecessary side effects from chemotherapy and radiation, this approach might also be the most cost-effective option for men with a form of early ...

News

Newly Discovered Cells Shed Light on Immunotherapy in Kidney Cancer

Finding new potential biomarkers and targets for treating kidney cancer.

News

The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer

Extracting these vesicles from the blood and urine could make it possible to diagnose kidney cancer noninvasively.

News

Shedding Light on the “Trickle-Down” Effect of Mutated Genes in Kidney Cancer

“We have identified candidate drug targets that have been explored in other cancer types, but have yet to be evaluated in ccRCC.”

News

Our Multidisciplinary Kidney Cancer Group

Meet our two new faculty – who, with Phillip Pierorazio, M.D., newly named Director of the Kidney Cancer Program – form a multidisciplinary and translational kidney cancer group.

News

If Bladder Cancer Responds Well to Chemotherapy, Is It Safe to Skip the Cystectomy?

Who needs surgical removal of the bladder (radical cystectomy)? And who doesn’t need it? Unfortunately, that question is still very hard to answer.

News

Can Biomarkers Predict Who Will Benefit from Chemotherapy in Bladder Cancer?

New tests could identify who will benefit from chemotherapy, and spare those who will not.

News

Tackling a Rare, Aggressive Form of Cancer

It turns out that small cell neuroendocrine bladder carcinoma has a lot in common with small cell neuroendocrine lung cancer, and this may lead to new strategies for treatment.

News

New Immunotherapy Targets: B Cells

B cells play a vital role in the immune response against cancer.

News

Targeting Hypoxia in Bladder Cancer

The Brady team is investigating whether these cancers are uniquely sensitive to therapies that target tumor blood vessels.

News

Coulter Joins Research Faculty

Could timing make a difference with drugs that target the androgen receptor, combined with radiation and other treatments?

News

When PSA Comes Back: GC Test Helps Predict Risk of Metastasis

Phuoc Tran, M.D., Ph.D., professor of radiation oncology and molecular radiation sciences, oncology, and urology, is working to push the boundaries of curable cancer.

News

PSMA PET/CT with PyL Reaches a Key Milestone toward Approval

“PyL PET/CT detected localized disease in most men with biochemical recurrence presenting with negative or equivocal conventional imaging, and led to changes in management in the majority of patients.”

News

Targeting “Non-Coding” Genes for Prostate Cancer

In the search for better treatments for prostate cancer, protein-coding genes – genes that make proteins that cancer needs to grow and spread – have been a major focus of scientific attention.

News

Genes, Race, and Prostate Cancer

Understanding why African American men are at higher risk of aggressive cancer.

News

Prostate Cancer Immuno-therapy: A New Target

“Despite enrolling patients who had a high risk of prostate cancer recurrence, the majority of these men receiving Enoblituzumab remain cancer-free for 12 months or more after prostatectomy.”

News

New Imaging Techniques Highlight Specific Erection Nerves

Four decades ago, after his discovery of the bundles of nerves that control erection, Patrick Walsh, M.D., performed the first purposeful nerve-sparing radical prostatectomy.

News

Making Robotic Prostatectomy Even More Minimally Invasive

A new da Vinci robotic system involves only one small incision, near the patient’s navel. How does it compare to the standard robotic prostatectomy?

News

Just Invented: A Robotic Ultrasound Probe for the Prostate

Stoianovici’s lab has built a prototype of the new probe, and used it in preclinical tests – that were so promising, the FDA has approved the device for clinical trials.

News

40th Anniversary of a Lifesaving Discovery

In 1982, only 7 percent of men with prostate cancer underwent surgery. By 1992, 70 percent of men in their 50s and half of men in their 60s underwent surgery. That year, 100,000 radical prostatectomies were performed. By 2002, deaths from ...

News

SelectMDx: Could This Be a “Liquid Biopsy” for Active Surveillance?

For years, scientists have been searching for a liquid biopsy, a noninvasive test using blood or urine that could provide information about the aggressiveness of a man’s prostate cancer.

News

A New Urine Test for Aggressive Prostate Cancer?

The test looks for proteins in the urine that are made by clinically significant prostate cancer.

News

SelectMDx: Could This Be a “Liquid Biopsy” for Active Surveillance?

Nobody likes prostate biopsy. In fact, says epidemiologist Bruce J. Trock, M.P.H., Ph.D., the Frank Hinman, Jr. Professor in Urology, this is a major reason why men with low-risk prostate cancer, who otherwise could stay in active surveillance, ...

News

“Robust, Innovative, Forward-Thinking” - Personalized Active Surveillance, Safer Surgery

“It’s not just, ‘Your PSA is now 4, it used to be 3,’ but, ‘there’s an approximately 17-percent chance that you are harboring more aggressive cancer.”

News

Slowing Down Prostate Cancer

This novel therapy slowed the growth in 93 percent of mice with prostate cancer, and 53 percent of mice with pancreatic cancer.

News

A Challenging Year

Partin: “Even in a global pandemic, our mission remains the same: to defeat urologic disease.”

News

Infection, Inflammation, and Prostate Cancer: “Smoking Gun” Evidence!

Because of the unique molecular tools used in this study, Sfanos, De Marzo and colleagues were able to catch the formation of these invasive cancers in real time.

News

Big Data Helps Shape A New Model for Live Kidney Donation

A tool developed by Morgan Grams, MD, PhD, screens potential kidney donor candidates by estimating their own chance of developing kidney disease, and it has been widely adopted by renal specialists around the globe.

News

In Active Surveillance, Some Small Kidney Tumors Just Go Away

Discovery Winter 2019

News

HOXB13 and AR-V7: Genetic Partners in Crime

Discovery Winter 2019

News

The DISSRM: Nearly a Decade of Patient-Specific Treatment

Discovery Winter 2019

News

A Powerful Immunotherapy Mix for Bladder Cancer

Discovery Winter 2019

News

Neoadjuvant Chemotherapy And Upper Tract Urothelial Cancer

Discovery Winter 2019

News

“Liquid Biopsy” and Personalized Treatment for Bladder Cancer

Discovery Winter 2019

News

In Bladder Cancer, the Subtype Matters

Discovery Winter 2019

News

Remembering Donald S. Coffey

Discovery Winter 2019

News

Identifying Genes through Discovery

Discovery Winter 2019

News

If You Have Lymph Node Metastases After Radical Prostatectomy, What Should You Do?

Discovery Winter 2019

News

“We’ve Got a Team.”

Discovery Winter 2019

News

Not So Many Biopsies in Active Surveillance?

Discovery Winter 2019

News

Could Inherited Gene Mutations Affect Men in Active Surveillance?

Discovery Winter 2019

News

“Liquid Biopsy” for Advanced Prostate Cancer Spots Tiny Danger Signs Sooner

Discovery Winter 2019

News

A Key Target in Aggressive Prostate Cancer May Lead to New Drug Development

Discovery Winter 2019

News

Combination Immunotherapy Combats AR-V7+ Prostate Cancer

Discovery Winter 2019

News

What’s the Best Way to Treat Localized, Gleason 9-10 Prostate Cancer?

Discovery Winter 2019

News

New Device Extracts CTCs From Blood

Discovery Winter 2019

News

End-of-Radiation PSA and Intermediate- Risk Cancer

Discovery Winter 2019

News

Prostate Cancer Therapy and the Gut Microbiome

Discovery Winter 2019

News

Could Some Intermediate- Risk Men Do Active Surveillance?

Discovery Winter 2019

News

PSMA-PET Data System

Discovery Winter 2019

News

Thinking About Cancer in New Ways

Discovery Winter 2019

News

Breaking Prostate Cancer’s Control Over the Immune System

Discovery Winter 2019

News

Pain Control after Radical Prostatectomy

Discovery Winter 2019

News

Liver Fibrosis and PSA

Discovery Winter 2019

News

Custom-Tailored Prostate Biopsy

Discovery Winter 2019

News

A Genetic Target to Help the Immune System Fight Cancer

Discovery Winter 2019

News

Dangerous Genes

Discovery Winter 2019

News

Single Blood Test Screens for Eight Cancer Types

News Release January 18, 2018

News

High Blood Sugar and Prostate Cancer

Discovery Winter 2018

News

When Can PSA Testing Be Stopped After Prostatectomy?

Discovery Winter 2018

News

Pushing Back the Frontier of Curability

Discovery Winter 2018

News

The Protein that Makes Metastasis Possible

Discovery Winter 2018

News

A Molecular Marker for Aggressive Penile Cancer

Discovery Winter 2018

News

Brady Urologists Shape National Guidelines for Kidney Cancer

Discovery Winter 2018

News

A “Liquid Biopsy”for Advanced Prostate Cancer

Discovery Winter 2018

News

Helping the Immune System Fight Prostate Cancer

Discovery Winter 2018

News

Immunotherapy in Bladder Cancer: Encouraging Results Prompt FDA Approval

Discovery Winter 2018

News

“You’re Not Going to Die From This.”

Discovery Winter 2018

News

Hopkins-Led Study Proves Active Surveillance is Safe for Small Kidney Tumors

Discovery Winter 2018

News

The Great Promise of PSMA-Targeting Agents

Discovery Winter 2018

News

Putting Positive Surgical Margins into Perspective

Discovery Winter 2018

News

Preserving the Treasure Trove of Prostate Tissue

Discovery Winter 2018

News

Immunotherapy Offers Hope for Men With Advanced Prostate Cancer

Discovery Winter 2018

News

A New Target in Preventing Metastasis

Discovery Winter 2018

News

Good News for Men with Advanced Prostate Cancer

Discovery Winter 2018

News

Many Small Kidney Tumors Don’t Need to be Treated

Discovery Winter 2018

News

Bladder Cancer: Precision Diagnosis is Critical

Discovery Winter 2018

News

Read About the Research You Have Helped Make Possible

Discovery Winter 2018

News

A “Liquid Biopsy”for Advanced Prostate Cancer

Discovery Winter 2018

News

Finding and Treating Stray Cancer Cells Sooner than Ever

Discovery Winter 2018

News

Helping the Immune System Fight Prostate Cancer

Discovery Winter 2018

News

Good News for Men with Advanced Prostate Cancer

Discovery Winter 2018

News

Better Treatment for Aggressive Prostate Cancer

OnTarget 2017/2018

News

Breaking DNA and Killing Cancer

Discovery January 01, 2017

News

A “Sweeter” PSA Test

Discovery January 01, 2017

News

Momentum and Hope through Discovery

Discovery January 01, 2017

News

Precision Brachytherapy, Using Real-Time X-Rays

Discovery January 01, 2017

News

Mast Cells Linked to Risk of Cancer Recurrence

Discovery January 01, 2017

News

Nobody Connected These Genes With Lethal Prostate Cancer, Until Now

Discovery January 01, 2017

News

Is Cancer Aggressive? Soon, You May Take a Urine Test to Find Out

Discovery January 01, 2017

News

Immunotherapy for Kidney Cancer: Who are the “Exceptional Responders?”

Discovery January 01, 2017

News

Is the Androgen Receptor also responsible for bladder cancer development and progression?

Discovery January 01, 2017

News

Healthy Men Over 75: Don't Stop PSA Screening

Discovery January 01, 2017

News

End-of-Radiation PSA Helps Predict the Success of Treatment

Discovery January 01, 2017

News

Reassurance for Men on Active Surveillance

Discovery January 01, 2017

News

Studying the Seeds of Metastasis

Discovery January 01, 2017

News

Who Should Have Chemotherapy Before Surgery?

Discovery January 01, 2017

News

Zarif Wins PCF Young Investigator Award

Discovery January 01, 2017

News

Prostate Cancer Test Results May Differ in African American Men

Discovery January 01, 2017

News

Testicular Cancer: High Cure Rates, Complex Treatment

Discovery January 01, 2017

News

PHI Blood Test Spares Men from Unneeded Biopsy

Discovery January 01, 2017

News

At Last, a Mouse Model for the Worst Prostate Cancer in Men

Discovery January 01, 2017

News

Men Who Quit Smoking Are Less Likely to Die of Prostate Cancer

Discovery January 01, 2017

News

Some High-Grade PIN Is Actually Cancer

Discovery January 01, 2017

News

Biomarkers to Predict Aggressive Cancer

Discovery January 01, 2017

News

Same PSA, But Not the Same Cancer

Discovery January 01, 2017

News

Active Surveillance for Small Kidney Tumors

Discovery January 01, 2017

News

Where’s the Cancer? Now We Can See It

Discovery January 01, 2017

News

Next-Generation Therapy for Early Bladder Cancer: Nanoparticles

Discovery January 01, 2017

News

McConkey New Director of Greenberg Institute

Discovery January 01, 2017

News

Targeted Biopsy: A Smarter Way to Take Prostate Tissue Samples

Discovery January 01, 2017

News

Web Application Predicts Status of Low-Risk Prostate Cancer

Insight September 28, 2016

News

Capturing Cancer Cells in the Bone, Years Before They Cause Trouble

Discovery January 25, 2016

News

At Last, a Desperately Needed Mouse Model of Aggressive Prostate Cancer

Discovery January 25, 2016

News

Taking "AIM"at Invasive Cancer

Discovery January 25, 2016

News

Could Nerve-Sparing Brachytherapy Help Preserve Sexual Function?

Discovery January 25, 2016

News

New Tests Show Genetic Changes Linked to Aggressive Prostate Cancer

Discovery January 25, 2016

News

Two Non-Cancerous Causes for Higher PSA

Discovery January 25, 2016

News

Potential New Pathway to Kill Prostate Cancer

Discovery January 25, 2016

News

For Men with Advanced Prostate Cancer: New Hopkins Test Can Tell if Some Drugs Won't Work

Discovery January 25, 2016